ProtoKinetix AAGP™ Showcased at GECO47

PROTOKINETIX INC. (PKTX: OTCBB)
Vancouver, British Columbia, August 08, 2006

ProtoKinetix, Inc. is pleased to report on the outstanding reception AAGP™ received from the scientific and pharmaceutical establishments attending this prestigious symposium. PKTX has been requested by several pharmaceutical companies to collaborate with them on a variety of exciting new applications for the family of AAGP™ molecules.

This presentation, delivered by Dr. Geraldine Deliencourt on behalf of INSA (France’s Institute of Applied Sciences) and ProtoKinetix, was the first scientific peer review of the AAGP™ molecules. The Company and INSA were extremely gratified by the wide range of interest and absolute acceptance of this innovative technology. A copy of the presentation  abstract is available on our website.

About ProtoKinetix:
ProtoKinetix Inc is a Biotechnical Company dedicated to the development of a family of synthetic antifreeze glycoproteins (AAGP™) for human and veterinary medicine, the bio technology and cosmetic industries, and as a food additive. Using previously published research on native antifreeze proteins and antifreeze glycoproteins as a guide, and coordinating a vast pool of world recognized intellectual talent in a networked environment, PKTX is conducting rapid and meaningful research with a view to developing markets for this very useful family of molecules. Sign up for free automatic email news alerts at our new website at: www.protokinetix.com

The Private Securities Litigation  Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commision.

On behalf of the Board of Directors

Dr. John Todd – President

Company Office:   
Suite # 1500 885 West Georgia Street
Vancouver, BC V6C 3E8

Investor Contact:
ProtoKinetix
Blair Henderson
604-687-9887